Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Gennex Laboratories Ltd

Your Vote -

Buy

70.00%

Hold

10.00%

Sell

20.00%

70.00%

20 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Gennex Laboratories Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Gennex Laboratories - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    22 Apr 2025, 2:21PM With reference to the captioned subject matter, pursuant to Regulation 74(5) of SEBI (DP) Regulations, 2018, we hereby submit the certificate received
  • Gennex Laboratories has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025

    16 Apr 2025, 7:41PM As of March 2025, 18.41% is owned by Indian Promoters and 81.58% by Public. <p align=justify> Top five Promoters holding highest number of shares of G
  • Gennex Laboratories - Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regul

    24 Mar 2025, 11:46AM The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SE
  • Gennex Laboratories - Integrated Filing (Financial)

    3 Mar 2025, 6:35PM Pursuant to SEBI Circular No. SEBI/HO/CFD/CFD-PoD-2/CIR/P/2024/185 dated December 31, 2024 and BSE Notice No. 20250102-4 dated January 02, 2025 and yo
  • Gennex Laboratories Q3 net profit jumps 59.47% at Rs 4.21 cr

    14 Feb 2025, 7:30PM The company reported standalone net profit of Rs 4.21 crore for the quarter ended December 31, 2024 as compared to Rs 2.64 crore in the same period la
  • Gennex Laboratories - Unaudited Financial Results For Quarter And Nine Months Ended December 31, 2024

    14 Feb 2025, 7:00PM In just concluded Meeting of Board of Directors, the Board considered and approved the following items:\r\n\r\n1. Unaudited (Standalone and Consolidat
  • Gennex Laboratories - Board Meeting Outcome for Outcome Of The Board Meeting Of Gennex Laboratories Limited

    14 Feb 2025, 6:44PM In just concluded Meeting of Board of Directors, the Board considered and approved the following items\r\n\r\n1. Unaudited (Standalone and Consolidate
  • Gennex Laboratories - Statement Of Deviation Or Variation In The Use Of Proceeds Pursuant To Regulations 32 Of The SEBI (List

    14 Feb 2025, 5:49PM Pursuant to Regulation 32 of SEBI (LODR) Regulations, 2015, we hereby confirm that there is no deviation or variation in the use of the proceeds durin
  • Gennex Laboratories - Announcement under Regulation 30 (LODR)-Resignation of Director

    14 Feb 2025, 5:31PM With reference to above captioned subject, this is to inform you that Mr. Mohammed Khaleequr Rahman, Non-Executive Non-Independent Director has tender
  • Gennex Laboratories - Announcement under Regulation 30 (LODR)-Change in Management

    10 Feb 2025, 4:19PM With reference to our intimation dated November 14, 2024 regarding appointment of Chief Financial Officer and your query vide email dated January 20,

Key fundamentals

Evaluate the intrinsic value of Gennex Laboratories Ltd stock 

Name March-24 March-23 March-22 March-21 March-20
Assets 171.6065 80.0009 54.1213 47.2541 40.8383
Liabilities 171.6065 80.0009 54.1213 47.2541 40.8383
Equity 22.7447 18.0192 12.6503 12.6503 12.6503
Gross Profit 12.4188 4.5829 5.378 6.5333 3.2471
Net Profit 11.7979 4.5589 3.9232 4.0381 1.8563
Cash From Operating Activities -33.4279 -14.4505 6.6361 -1.4371 -1.6712
NPM(%) 17.66 7 6.4 6.76 3.33
Revenue 66.7987 65.0981 61.2137 59.6489 55.6173
Expenses 54.3798 60.5151 55.8357 53.1156 52.3701
ROE(%) 6.53 2.52 2.17 2.23 1.02

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Gennex Laboratories Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 827.00 0.24 11.74 7.44 1321.50 1.38
Lotus Eye Hospital and Institute Ltd 80.93 0.65 339.54 27.12 14.01 0.61
Bharat Immunological and Biologicals Corporation Ltd 22.70 -0.92 0.00 56.31 -39.50 0.00
Astec Lifesciences Ltd 672.50 -1.84 0.00 25.57 -687.11 0.00

Company Info

PRUDENTIAL PHARMACEUTICALS LIMITED was originally incorporated under the name of Pharmasia Drugs and Chemicals Private Limited on 25th June, 1985 in the state of Karnataka. The Company was subsequently shifted to Andhra Pradesh with effect from 29th March, 1990. The Company has been promoted by Pharmasia Limited, a Company registered under the Companies Act, 1956 and having its registered office at 49, BHEL Enclave, Akbar Road, Secunderabad - 500 003. The Company had acquired a sick bulk drug manufacturing unit of SPS Chemicals Private Limited, a sick unit assisted by the Andhra Pradesh State Financial Corporation Limited, located at 133, Bollaram, Medak Dist., in an auction in January, 1993 by paying a lumpsum consideration of Rs.13.25 lacs and undertaking to pay off the term loan overdues amounting to Rs.24 lacs to APSFC which has since been paid off. The Company became a Deemed Public Limited Company with effect from 6th February, 1993 as per the provisions of section 43A(1) of the Companies Act, 1956. The Company was converted to a Public Limited Company by a resolution passed by its members at the Extraordinary General Body Meeting held on 3rd November, 1994. A fresh certificate of incorporation consequent upon the conversion of the Company was issued by the Registrar of Companies, Andhra Pradesh, on 15th February, 1995. The Company's name was subsequently changed to Prudential Pharmaceuticals Limited and a fresh certificate of incorporation consequent upon change of name of the Company was issued by the Registrar of Companies, Andhra Pradesh, on 22nd February, 1995. Mr.Vinod Baid & his associates, acquired the entire holding of Pharmasia Limited amounting to 1,40,018 shares at their face value, (the consideration for which has been paid in cash) in November, 1994 with a view to implement the project to set up facilities for manufacturing bulk drugs. The controlling interest held by the erstwhile promoter group was acquired by Mr.Vinod Baid & Associates by transfer of shares by following the procedure set out in the Companies Act, 1956 and the rules framed there under i.e. by executing transfer deeds in prescribed form in favour of the transferees. At the time of take-over, the Company had certain plant and machinery which has been detailed elsewhere in the prospectus and had also placed orders for certain other plant and machinery. After the takeover, the company under the new management had taken up the implementation of the project in right earnest. The products were identified, additional equipment required (other than those already available and those ordered) were acquired and the manpower required for manning the project were hired. The trial production was completed in September, 1995 and the Commercial Production has already commenced. 2007 - Company name has been changed from Prudential Pharmaceuticals Ltd to Gennex Laboratories Ltd. 2009 -Company has splits its Face value of Shares from Rs 10 to Re 1. 2022 -The company issued rights shares of Rs. 1 in the ratio of 1:2 at a premium of Rs. 5 per share.

PRUDENTIAL PHARMACEUTICALS LIMITED was originally incorporated under the name of Pharmasia Drugs and Chemicals Private Limited on 25th June, 1985 in the state of Karnataka. The Company was subsequently shifted to Andhra Pradesh with effect from 29th March, 1990. The Company has been promoted by Pharmasia Limited, a Company registered under the Companies Act, 1956 and having its registered office at 49, BHEL Enclave, Akbar Road, Secunderabad - 500 003. The Company had acquired a sick bulk drug manufacturing unit of SPS Chemicals Private Limited, a sick unit assisted by the Andhra Pradesh State Financial Corporation Limited, located at 133, Bollaram, Medak Dist., in an auction in January, 1993 by paying a lumpsum consideration of Rs.13.25 lacs and undertaking to pay off the term loan overdues amounting to Rs.24 lacs to APSFC which has since been paid off. The Company became a Deemed Public Limited Company with effect from 6th February, 1993 as per the provisions of section 43A(1) of the Companies Act, 1956. The Company was converted to a Public Limited Company by a resolution passed by its members at the Extraordinary General Body Meeting held on 3rd November, 1994. A fresh certificate of incorporation consequent upon the conversion of the Company was issued by the Registrar of Companies, Andhra Pradesh, on 15th February, 1995. The Company's name was subsequently changed to Prudential Pharmaceuticals Limited and a fresh certificate of incorporation consequent upon change of name of the Company was issued by the Registrar of Companies, Andhra Pradesh, on 22nd February, 1995. Mr.Vinod Baid & his associates, acquired the entire holding of Pharmasia Limited amounting to 1,40,018 shares at their face value, (the consideration for which has been paid in cash) in November, 1994 with a view to implement the project to set up facilities for manufacturing bulk drugs. The controlling interest held by the erstwhile promoter group was acquired by Mr.Vinod Baid & Associates by transfer of shares by following the procedure set out in the Companies Act, 1956 and the rules framed there under i.e. by executing transfer deeds in prescribed form in favour of the transferees. At the time of take-over, the Company had certain plant and machinery which has been detailed elsewhere in the prospectus and had also placed orders for certain other plant and machinery. After the takeover, the company under the new management had taken up the implementation of the project in right earnest. The products were identified, additional equipment required (other than those already available and those ordered) were acquired and the manpower required for manning the project were hired. The trial production was completed in September, 1995 and the Commercial Production has already commenced. 2007 - Company name has been changed from Prudential Pharmaceuticals Ltd to Gennex Laboratories Ltd. 2009 -Company has splits its Face value of Shares from Rs 10 to Re 1. 2022 -The company issued rights shares of Rs. 1 in the ratio of 1:2 at a premium of Rs. 5 per share.

Read More

Parent Organisation

Gennex Laboratories Ltd.

Founded

29/03/1990

Managing Director

Mr.Arihant Baid

NSE Symbol

FAQ

The current price of Gennex Laboratories Ltd is

The 52-week high for Gennex Laboratories Ltd is

The market capitalization of Gennex Laboratories Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Gennex Laboratories Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Gennex Laboratories Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Gennex Laboratories Ltd shares.

The CEO of Gennex Laboratories Ltd is Mr.Arihant Baid, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT